P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision
P/0502/2022 : EMA decision of 1 December 2022 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for obinutuzumab (Gazyvaro), (EMEA-001207-PIP06-22)